PT Kedoya Adyaraya Tbk (RSGK.JK)
IDR 990.0
(-1.0%)
IDR 990.0
(-1.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - IDR | -100.0% |
| 2022 | 575.39 Million IDR | -98.09% |
| 2021 | 30.15 Billion IDR | -81.07% |
| 2020 | 159.3 Billion IDR | 1.27% |
| 2019 | 157.3 Billion IDR | 21.22% |
| 2018 | 129.76 Billion IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - IDR | 0.0% |
| 2024 Q2 | - IDR | 0.0% |
| 2024 Q3 | - IDR | 0.0% |
| 2023 Q1 | 144.76 Million IDR | -74.84% |
| 2023 Q4 | - IDR | 0.0% |
| 2023 Q3 | - IDR | 0.0% |
| 2023 FY | - IDR | -100.0% |
| 2023 Q2 | - IDR | -100.0% |
| 2022 Q2 | 23.85 Billion IDR | -4.73% |
| 2022 FY | 575.39 Million IDR | -98.09% |
| 2022 Q4 | 575.39 Million IDR | -47.02% |
| 2022 Q3 | 1.08 Billion IDR | -95.45% |
| 2022 Q1 | 25.03 Billion IDR | -16.95% |
| 2021 Q3 | 149.48 Billion IDR | 0.0% |
| 2021 FY | 30.15 Billion IDR | -81.07% |
| 2021 Q1 | - IDR | -100.0% |
| 2021 Q2 | - IDR | 0.0% |
| 2021 Q4 | 30.15 Billion IDR | -79.83% |
| 2020 FY | 159.3 Billion IDR | 1.27% |
| 2020 Q4 | 159.3 Billion IDR | 0.0% |
| 2019 FY | 157.3 Billion IDR | 21.22% |
| 2018 FY | 129.76 Billion IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Bundamedik Tbk | 1119.95 Billion IDR | 100.0% |
| PT Metro Healthcare Indonesia Tbk | 954.51 Billion IDR | 100.0% |
| PT Medikaloka Hermina Tbk | 2260.89 Billion IDR | 100.0% |
| PT Mitra Keluarga Karyasehat Tbk | 3.05 Billion IDR | 100.0% |
| PT Murni Sadar Tbk | 495.02 Billion IDR | 100.0% |
| PT Famon Awal Bros Sedaya Tbk | 1278.14 Billion IDR | 100.0% |
| PT Royal Prima Tbk | - IDR | NaN% |
| PT Sarana Meditama Metropolitan Tbk | 963.22 Billion IDR | 100.0% |
| PT Siloam International Hospitals Tbk | 647.1 Billion IDR | 100.0% |
| PT Sejahteraraya Anugrahjaya Tbk | 1650.23 Billion IDR | 100.0% |